Mavenclad resulted in stable/better cognitive function and stable employment status over 2 years in highly active relapsing ...

Living with MS means adjusting to new challenges, and for columnist Desiree Lama, one of those things is an itch she can't ...

The National MS Society launched the Mendoza Family Fund in partnership with football player Fernando Mendoza and his family.

An animal study suggests short-term brain inflammation may help repair myelin and could inform future repair-focused ...

Medthera's WalkPort is designed to help people with mobility and gait issues, including those with MS, safely stand and ...

A committee in the EU recommended that tolebrutinib, to be sold as Cenrifki, be approved for people with SPMS with no relapses for two years.

Guest writer Lindsay Kelly describes the shift she experienced in terms of the resentment she'd felt about her husband's ...

The experimental drug fenebrutinib worked better than Aubagio, an approved therapy, for reducing relapse rates in MS, new ...

Columnist Ben Hofmeister reflects on the feelings of guilt that surfaced after writing that his present vehicle no longer met his needs.

Medicaid coverage of highly effective disease-modifying therapies for MS varies widely across the U.S., with no coverage in ...

Scientists studying animals at high altitudes discovered a previously unknown mechanism that is key for regulating myelin ...

Columnist Desiree Lama is reconnecting with her love of plants and being outside after starting an outdoor garden at her new ...